cccDNA SILENCING AND LIMITED DECAY OF INFECTED CELLS IN HIV-HBV (HBeAG-) DURING NUCs
Background: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) is characterized by lower serum HBV DNA levels than HBeAg-positive CHB. Nucleos(t)ide analogues (NUC), the mainstay of treatment for CHB, effectively suppress HBV replication and are associated with decreased covalently closed circular DNA (cccDNA) transcription in HBeAg-positive disease. However, the effects of NUCs on the…